Evidence
White papers
In-depth technical and scientific papers exploring how mechanistic modeling and clinical trial simulation reshape drug development.
Answers Are Not Insights
A look at why AI-generated trial design answers still need human insight, and how Jinkō helps teams trace and own the reasoning behind them.
How to Support the Use of AI in Clinical Trials in France ?
A comprehensive look at the most pressing challenges in clinical research and how the Jinko platform helps address them through innovative clinical trial design.
New methods for improving external control arms
External Control Arms (ECA) address some of the practical, ethical and cost challenges of recruiting in-trial randomized control arms. Yet ECAs have their own limitations.
Model-informed Drug Development (MiDD) at nova
Nova’s modeling and simulation approach combines mathematical models of diseases and treatments with virtual patients into an integrated clinical trial simulation platform called jinkō.
The case for in silico trials
This e-book gives a comprehensive overview of nova’s industry-leading approach to drug development.
In silico clinical trials
In silico is emerging as the 3rd pillar of the drug R&D paradigm, in support of - not a full substitute to - more conventional in vitro and in vivo exploration and evidence-generation techniques.